Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Nicholas D. Beyda"'
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT The human microbiome project has revolutionized our understanding of the interaction between commensal microbes and human health. By far, the biggest perturbation of the microbiome involves use of broad-spectrum antibiotics excreted in the g
Externí odkaz:
https://doaj.org/article/0de979f4e47447b998690b0607f460c4
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT Here, we report two paired sets of an index wild-type Candida glabrata bloodstream isolate and subsequent echinocandin-resistant FKS mutant. One paired set exhibited a higher proportion of clumping cells and was more virulent in the inverteb
Externí odkaz:
https://doaj.org/article/b76fd398759e481985cc3101204bfc51
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::640dd2ca9948dd556327ff0c42a0ce50
https://doi.org/10.1002/phar.2804
https://doi.org/10.1002/phar.2804
Autor:
Jinhee Jo, Truc T. Tran, Nicholas D. Beyda, Debora Simmons, Joshua A. Hendrickson, Masaad Saeed Almutairi, Faris S. Alnezary, Anne J. Gonzales-Luna, Edward J. Septimus, Kevin W. Garey
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 41(10)
Patients with invasive candidiasis (IC) have complex medical and infectious disease problems that often require continued care after discharge. This study aimed to assess echinocandin use at hospital discharge and develop a transition of care (TOC) m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bc6443a5d765c3ed7f941e6358b51a1
https://pubmed.ncbi.nlm.nih.gov/36002777
https://pubmed.ncbi.nlm.nih.gov/36002777
Autor:
Rachel J. Musgrove, Kevin W. Garey, Todd M. Lasco, Raymond Yau, Nicholas D. Beyda, Amelia K. Sofjan, Hannah Palmer Russo, Alejandro Restrepo
Publikováno v:
Journal of Global Antimicrobial Resistance. 15:41-47
Objectives The epidemiology of spontaneous bacterial peritonitis (SBP) due to ceftriaxone-resistant organisms has not been well studied in the USA. The primary objective of this study was to assess the prevalence and predictors of ceftriaxone-resista
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af5a5bdec4a967db6cf1f68a59d82197
https://doi.org/10.1016/j.jgar.2018.05.015
https://doi.org/10.1016/j.jgar.2018.05.015
Autor:
Kevin W. Garey, Amelia K. Sofjan, Ardath Mitchell, Nicholas D. Beyda, Mui Sim, Dhara N. Shah, Ashley Trojcak, Tam Nguyen
Publikováno v:
Journal of Global Antimicrobial Resistance. 14:58-64
Objectives Rezafungin (CD101) is a novel echinocandin currently under development. The purpose of this study was to perform a systematic literature review of published evidence on rezafungin and an antimicrobial stewardship audit of real-world use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc9d2eb85177f434a5c91559b445450d
https://doi.org/10.1016/j.jgar.2018.02.013
https://doi.org/10.1016/j.jgar.2018.02.013
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 37:1347-1356
tudy Objective To determine whether early administration of adjuvant β-lactam in combination with vancomycin (COMBO) affects clinical outcomes compared to standard vancomycin therapy alone (STAN) among patients with methicillin-resistant Staphylococ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53a66e00d42af162d9cc1ff3548941e4
https://doi.org/10.1002/phar.2034
https://doi.org/10.1002/phar.2034
Publikováno v:
Current infectious disease reports. 21(12)
The global emergence of antifungal resistance among Candida spp. and Aspergillus spp. is a growing threat to public health, driven largely by the expanding use of antifungals in both the clinical and agricultural settings. As treatment options remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::018424fdb4ada8aad772ebe7cb0d0b6a
https://pubmed.ncbi.nlm.nih.gov/31734730
https://pubmed.ncbi.nlm.nih.gov/31734730
Autor:
Thomas J Dilworth, Omar M. Ibrahim, Dana R Bowers, Nicholas D. Beyda, David M. Jacobs, Anthony M. Casapao, Renee-Claude Mercier
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
We analyzed the impact of vancomycin (VAN) combined with adjuvant β-lactam therapy (Combo) on persistent (≥5 days) methicillin-resistant Staphylococcus aureus bacteremia versus VAN alone by using pooled data from two previously published observati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b04d458e87c60d8ac5f52f8e27bb219a
https://doi.org/10.1128/aac.02211-18
https://doi.org/10.1128/aac.02211-18
Autor:
Nathaniel D. Albert, Sebastian Wurster, Dimitrios P. Kontoyiannis, Nicholas D. Beyda, Russell E. Lewis
We compared the in vitro pharmacodynamics of isavuconazole, voriconazole, and posaconazole against 92 clinical isolates from documented cases of invasive aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis. Whereas inhibitory and fungicida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87a2a780bab092f338b0a4be8e2e1e54
http://hdl.handle.net/11585/731398
http://hdl.handle.net/11585/731398
